Reliability and validity of methods for measuring the duration of untreated psychosis: A quantitative review and meta-analysis

Schizophrenia Research

Volumn 160, Issue 1-3, 2014, Pages 20-26

  Register Brown, Kelly ^a   Hong, L Elliot ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

Author keywords

Duration of untreated psychosis; Meta analysis; Schizophrenia

Indexed keywords

ARTICLE; BASEL INTERVIEW FOR PSYCHOSIS; BEISER SCALE; CIRCUMSTANCES OF ONSET AND RELAPSE SCHEDULE; COMPREHENSIVE ASSESSMENT OF SYMPTOMS AND HISTORY; DISEASE DURATION; EVIDENCE BASED MEDICINE; HUMAN; INTERVIEW; INTERVIEW FOR THE RETROSPECTIVE ASSESSMENT OF THE ONSET OF SCHIZOPHRENIA; INTRARATER RELIABILITY; META ANALYSIS (TOPIC); NEUROPSYCHOLOGICAL TEST; NOTTINGHAM ONSET SCHEDULE; ONSET AGE; OUTCOME ASSESSMENT; POSITIVE AND NEGATIVE SYNDROME SCALE; PREDICTION; PRIORITY JOURNAL; PSYCHIATRIC AND PERSONAL HISTORY SCHEDULE; PSYCHOSIS; QUANTITATIVE STUDY; RELIABILITY; ROYAL PARK MULTIDIAGNOSTIC INSTRUMENT FOR PSYCHOSIS; SYMPTOM ONSET IN SCHIZOPHRENIA INVENTORY; VALIDATION STUDY; META ANALYSIS; PROGNOSIS; PSYCHOLOGICAL RATING SCALE; PSYCHOTIC DISORDERS; REPRODUCIBILITY; TIME TO TREATMENT;

HUMANS; PROGNOSIS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; REPRODUCIBILITY OF RESULTS; TIME-TO-TREATMENT;

EID: 84928237855     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2014.10.025     Document Type: Article

References (56)

1. Alvarez-Jimenez M., Gleeson J.F., Cotton S., Wade D., Gee D., Pearce T., Crisp K., Spiliotacopoulos D., Newman B., McGorry P.D. Predictors of adherence to cognitive-behavioural therapy in first-episode psychosis. Can. J. Psychiatry 2009, 54(10):710-718.
2. Andreasen N.C., Flaum M., Arndt S. The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology.Arch. Gen. Psychiatry 1992, 49(8):615-623.
3. Beiser M., Erickson D., Fleming J.A., Iacono W.G. Establishing the onset of psychotic illness. Am. J. Psychiatry 1993, 150(9):1349-1354.
4. Bird V., Premkumar P., Kendall T., Whittington C., Mitchell J., Kuipers E. Early intervention services, cognitive-behavioural therapy and family intervention in early psychosis: systematic review. Br. J. Psychiatry 2010, 197(5):350-356.
5. Boonstra N., Klaassen R., Sytema S., Marshall M., De Haan L., Wunderink L., Wiersma D. Duration of untreated psychosis and negative symptoms-a systematic review and meta-analysis of individual patient data. Schizophr. Res. 2012, 142(1-3):12-19.
6. Bottlender R., Sato T., Jager M., Wegener U., Wittmann J., Strauss A., Moller H.J. The impact of the duration of untreated psychosis prior to first psychiatric admission on the 15-year outcome in schizophrenia. Schizophr. Res. 2003, 62(1-2):37-44.
7. Breitborde N.J., Srihari V.H., Woods S.W. Review of the operational definition for first-episode psychosis. Interv. Psychiatry 2009, 3(4):259-265.
8. Broussard B., Kelley M.E., Wan C.R., Cristofaro S.L., Crisafio A., Haggard P.J., Myers N.L., Reed T., Compton M.T. Demographic, socio-environmental, and substance-related predictors of duration of untreated psychosis (DUP). Schizophr. Res. 2013, 148(1-3):93-98.
9. Cascio M.T., Cella M., Preti A., Meneghelli A., Cocchi A. Gender and duration of untreated psychosis: a systematic review and meta-analysis. Interv. Psychiatry 2012, 6(2):115-127.
10. Chang W.C., Tang J.Y., Hui C.L., Lam M.M., Chan S.K., Wong G.H., Chiu C.P., Chen E.Y. Prediction of remission and recovery in young people presenting with first-episode psychosis in Hong Kong: a 3-year follow-up study. Aust.N.Z.J. Psychiatry 2012, 46(2):100-108.
11. Chang W.C., Hui C.L., Tang J.Y., Wong G.H., Chan S.K., Lee E.H., Chen E.Y. Impacts of duration of untreated psychosis on cognition and negative symptoms in first-episode schizophrenia: a 3-year prospective follow-up study. Psychol. Med. 2013, 43(9):1883-1893.
12. Chou P.H., Koike S., Nishimura Y., Kawasaki S., Satomura Y., Kinoshita A., Takizawa R., Kasai K. Distinct effects of duration of untreated psychosis on brain cortical activities in different treatment phases of schizophrenia: a multi-channel near-infrared spectroscopy study. Prog. Neuropsychopharmacol. Biol. Psychiatry 2014, 49:63-69.
13. Clarke M., Whitty P., Browne S., Mc Tigue O., Kinsella A., Waddington J.L., Larkin C., O'Callaghan E. Suicidality in first episode psychosis. Schizophr. Res. 2006, 86(1-3):221-225.
14. Compton M.T., Carter T., Bergner E., Franz L., Stewart T., Trotman H., McGlashan T.H., McGorry P. Defining, operationalizing, and measuring the duration of untreated psychosis: advances, limitations and future directions. Interv. Psychiatry 2007, 1:236-250.
15. Compton M.T., Gordon T.L., Weiss P.S., Walker E.F. The "doses" of initial, untreated hallucinations and delusions: a proof-of-concept study of enhanced predictors of first-episode symptomatology and functioning relative to duration of untreated psychosis. J. Clin. Psychiatry 2011, 72(11):1487-1493.
16. Craig T.J., Bromet E.J., Fennig S., Tanenberg-Karant M., Lavelle J., Galambos N. Is there an association between duration of untreated psychosis and 24-month clinical outcome in a first-admission series?. Am. J. Psychiatry 2000, 157(1):60-66.
17. Cuesta M.J., Peralta V., Campos M.S., Garcia-Jalon E. Can insight be predicted in first-episode psychosis patients? A longitudinal and hierarchical analysis of predictors in a drug-naive sample. Schizophr. Res. 2011, 130(1-3):148-156.
18. de Haan L., Linszen D.H., Lenior M.E., de Win E.D., Gorsira R. Duration of untreated psychosis and outcome of schizophrenia: delay in intensive psychosocial treatment versus delay in treatment with antipsychotic medication. Schizophr. Bull. 2003, 29(2):341-348.
19. Dell'Osso B., Glick I.D., Baldwin D.S., Altamura A.C. Can long-term outcomes be improved by shortening the duration of untreated illness in psychiatric disorders? A conceptual framework. Psychopathology 2013, 46(1):14-21.
20. Diaz I., Pelayo-Teran J.M., Perez-Iglesias R., Mata I., Tabares-Seisdedos R., Suarez-Pinilla P., Vazquez-Barquero J.L., Crespo-Facorro B. Predictors of clinical remission following a first episode of non-affective psychosis: sociodemographics, premorbid and clinical variables. Psychiatry Res. 2013, 206(2-3):181-187.
21. Drake R.J., Haley C.J., Akhtar S., Lewis S.W. Causes and consequences of duration of untreated psychosis in schizophrenia. Br. J. Psychiatry 2000, 177:511-515.
22. Farooq S., Large M., Nielssen O., Waheed W. The relationship between the duration of untreated psychosis and outcome in low-and-middle income countries: a systematic review and meta analysis. Schizophr. Res. 2009, 109(1-3):15-23.
23. Fridgen G.J., Aston J., Gschwandtner U., Pflueger M., Zimmermann R., Studerus E., Stieglitz R.D., Riecher-Rössler A. Help-seeking and pathways to care in the early stages of psychosis. Soc. Psychiatry Psychiatr. Epidemiol. 2013, 48(7):1033-1043. 2013 Jul.
24. Friis S., Melle I., Larsen T.K., Haahr U., Johannessen J.O., Simonsen E., Opjordsmoen S., Vaglum P., McGlashan T.H. Does duration of untreated psychosis bias study samples of first-episode psychosis?. Acta Psychiatr. Scand. 2004, 110(4):286-291.
25. Fusar-Poli P., Borgwardt S., Bechdolf A., Addington J., Riecher-Rossler A., Schultze-Lutter F., Keshavan M., Wood S., Ruhrmann S., Seidman L.J., Valmaggia L., Cannon T., Velthorst E., De Haan L., Cornblatt B., Bonoldi I., Birchwood M., McGlashan T., Carpenter W., McGorry P., Klosterkotter J., McGuire P., Yung A. The psychosis high-risk state: a comprehensive state-of-the-art review. JAMA Psychiatry 2013, 70(1):107-120.
26. Gonzalez-Blanch C., Crespo-Facorro B., Alvarez-Jimenez M., Rodriguez-Sanchez J.M., Pelayo-Teran J.M., Perez-Iglesias R., Vazquez-Barquero J.L. Pretreatment predictors of cognitive deficits in early psychosis. Psychol. Med. 2008, 38(5):737-746.
27. Hafner H., Riecher-Rossler A., Hambrecht M., Maurer K., Meissner S., Schmidtke A., Fatkenheuer B., Loffler W., van der Heiden W. IRAOS: an instrument for the assessment of onset and early course of schizophrenia. Schizophr. Res. 1992, 6(3):209-223.
28. Hafner H., Maurer K., Loffler W., Fatkenheuer B., an der Heiden W., Riecher-Rossler A., Behrens S., Gattaz W.F. The epidemiology of early schizophrenia. Influence of age and gender on onset and early course. Br. J. Psychiatry 1994, (23):29-38. (23).
29. Ho B.C., Flaum M., Hubbard W., Arndt S., Andreasen N.C. Validity of symptom assessment in psychotic disorders: information variance across different sources of history. Schizophr. Res. 2004, 68(2-3):299-307.
30. Janca A., Chandrashekar C. Catalogue of Assessment Instruments Used in the Studies Coordinated by the WHO Mental Health Programme, Division of Mental Health. World Health Organization, Geneva 1993.
31. Killackey E., Yung A.R. Effectiveness of early intervention in psychosis. Curr. Opin. Psychiatry 2007, 20(2):121-125.
32. Large M.M., Nielssen O. Violence in first-episode psychosis: a systematic review and meta-analysis. Schizophr. Res. 2011, 125(2-3):209-220.
33. Large M., Nielssen O., Slade T., Harris A. Measurement and reporting of the duration of untreated psychosis. Early Interv. Psychiatry 2008, 2(4):201-211.
34. Larsen T.K., McGlashan T.H., Moe L.C. First-episode schizophrenia: I. Early course parameters. Schizophr. Bull. 1996, 22(2):241-256.
35. Larsen T.K., Friis S., Haahr U., Joa I., Johannessen J.O., Melle I., Opjordsmoen S., Simonsen E., Vaglum P. Early detection and intervention in first-episode schizophrenia: a critical review. Acta Psychiatr. Scand. 2001, 103(5):323-334.
36. Lihong Q., Shimodera S., Fujita H., Morokuma I., Nishida A., Kamimura N., Mizuno M., Furukawa T.A., Inoue S. Duration of untreated psychosis in a rural/suburban region of Japan. Interv. Psychiatry 2012, 6(3):239-246.
37. Lloyd-Evans B., Crosby M., Stockton S., Pilling S., Hobbs L., Hinton M., Johnson S. Initiatives to shorten duration of untreated psychosis: systematic review. Br. J. Psychiatry 2011, 198(4):256-263.
38. Lopez-Morinigo J.D., Wiffen B., O'Connor J., Dutta R., Di Forti M., Murray R.M., David A.S. Insight and suicidality in first-episode psychosis: understanding the influence of suicidal history on insight dimensions at first presentation. Interv. Psychiatry 2013, 8:113-121.
39. MacBeth A., Gumley A. Premorbid adjustment, symptom development and quality of life in first episode psychosis: a systematic review and critical reappraisal. Acta Psychiatr. Scand. 2008, 117(2):85-99.
40. Madsen A.L., Karle A., Rubin P., Cortsen M., Andersen H.S., Hemmingsen R. Progressive atrophy of the frontal lobes in first-episode schizophrenia: interaction with clinical course and neuroleptic treatment. Acta Psychiatr.Scand. 1999, 100(5):367-374.
41. Malla A.K., Norman R.M., Manchanda R., Ahmed M.R., Scholten D., Harricharan R., Cortese L., Takhar J. One year outcome in first episode psychosis: influence of DUP and other predictors. Schizophr. Res. 2002, 54(3):231-242.
42. Marshall M., Lewis S., Lockwood A., Drake R., Jones P., Croudace T. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Arch. Gen. Psychiatry 2005, 62(9):975-983.
43. Maurer K., Hafner H. Methodological aspects of onset assessment in schizophrenia. Schizophr. Res. 1995, 15(3):265-276.
44. McGlashan T.H. Duration of untreated psychosis in first-episode schizophrenia: marker or determinant of course?. Biol. Psychiatry 1999, 46(7):899-907.
45. McGorry P.D., Copolov D.L., Singh B.S. Royal Park Multidiagnostic Instrument for Psychosis: Part I. Rationale and review. Schizophr. Bull. 1990, 16(3):501-515.
46. McGorry P.D., Killackey E., Yung A.R. Early intervention in psychotic disorders: detection and treatment of the first episode and the critical early stages. Med. J. Aust. 2007, 187(7 Suppl.):S8-S10.
47. Moher D., Liberati A., Tetzlaff J., Altman D.G., The PRISMA Group Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med. 2009, 6(6):e1000097.
48. Norman R., Malla A. Duration of untreated psychosis: a critical examination of the concept and its importance. Psychol. Med. 2001, 31(3):381-400.
49. Norman R.M., Malla A.K., Verdi M.B., Hassall L.D., Fazekas C. Understanding delay in treatment for first-episode psychosis. Psychol. Med. 2004, 34(2):255-266.
50. Norman R.M., Lewis S.W., Marshall M. Duration of untreated psychosis and its relationship to clinical outcome. Br. J. Psychiatry Suppl. 2005, 48:s19-s23.
51. Perkins D.O., Leserman J., Jarskog L.F., Graham K., Kazmer J., Lieberman J.A. Characterizing and dating the onset of symptoms in psychotic illness: the Symptom Onset in Schizophrenia (SOS) inventory. Schizophr. Res. 2000, 44(1):1-10.
52. Perkins D.O., Gu H., Boteva K., Lieberman J.A. Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis. Am. J. Psychiatry 2005, 162(10):1785-1804.
53. Singh S.P. Outcome measures in early psychosis; relevance of duration of untreated psychosis. Br. J. Psychiatry Suppl. 2007, 50:s58-s63.
54. Singh S.P., Cooper J.E., Fisher H.L., Tarrant C.J., Lloyd T., Banjo J., Corfe S., Jones P. Determining the chronology and components of psychosis onset: The Nottingham Onset Schedule (NOS). Schizophr. Res. 2005, 80(1):117-130.
55. Takahashi T., Suzuki M., Tanino R., Zhou S.Y., Hagino H., Niu L., Kawasaki Y., Seto H., Kurachi M. Volume reduction of the left planum temporale gray matter associated with long duration of untreated psychosis in schizophrenia: a preliminary report. Psychiatry Res. 2007, 154(3):209-219.
56. Winsper C., Singh S.P., Marwaha S., Amos T., Lester H., Everard L., Jones P., Fowler D., Marshall M., Lewis S., Sharma V., Freemantle N., Birchwood M. Pathways to violent behavior during first-episode psychosis: a report from the UK National EDEN Study. JAMA Psychiatry 2013, 70(12):1287-1293.